Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1999
10/14/1999CA2324984A1 Secreted proteins and polynucleotides encoding them
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/14/1999CA2324381A1 An integrin heterodimer and a subunit thereof
10/14/1999CA2324378A1 Glaucoma therapeutics and diagnostics
10/14/1999CA2324284A1 Peptides causing formation of compact structures
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0949331A1 Established microglia
10/13/1999EP0948636A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
10/13/1999EP0948634A1 Nematode-inducible regulatory dna sequences
10/13/1999EP0948628A1 Method for the production of glycerol by recombinant organisms
10/13/1999EP0948624A2 Mutants of streptococcal toxin a and methods of use
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948619A1 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
10/13/1999EP0948617A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
10/13/1999EP0948614A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/13/1999EP0948611A1 Ve-cadherin promoter and its uses
10/13/1999EP0948610A1 Subtilase variants and compositions
10/13/1999EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999EP0948605A1 Truncated platelet-activating factor acetylhydrolase
10/13/1999EP0948604A2 Pyk2 related products and methods
10/13/1999EP0948602A1 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use
10/13/1999EP0948599A1 Protein kinases and uses thereof
10/13/1999EP0948598A1 Nucleic acid molecule encoding a 11-cis retinol dehydrogenase
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948595A1 MUTANT $i(OB) RECEPTORS AND NUCLEOTIDES ENCODING THEM
10/13/1999EP0948594A1 Method and device for microinjection of macromolecules into non-adherent cells
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948543A1 Hvem polypeptides and uses thereof
10/13/1999EP0948542A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/13/1999EP0948537A2 Protein binding fragments of gravin
10/13/1999EP0948532A1 Mouse galanin receptor galr2 and nucleotides encoding same
10/13/1999EP0948531A1 Secreted human proteins
10/13/1999EP0948530A2 Mammalian cell surface antigens; related reagents
10/13/1999EP0948529A1 Human galanin receptor galr2 and nucleotides encoding same
10/13/1999EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948516A1 Method for determining expression of aberrant forms of apc protein
10/13/1999EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999EP0948511A2 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/13/1999EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999EP0948323A1 Protease-activated receptor 3 and uses thereof
10/13/1999EP0948256A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
10/13/1999EP0948255A1 Improved chondrogenic differentiation of human mesenchymal stem cells
10/13/1999EP0948254A1 Cell control used to confirm enzymatic activity
10/13/1999EP0793502A4 Novel hedgehog-derived polypeptides
10/13/1999EP0652955B1 Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use
10/13/1999EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999EP0603307B1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same
10/13/1999EP0564592B1 Liver enriched transcription factor
10/13/1999CN1231702A Editing-based selectable plastid marker genes
10/13/1999CN1231698A DNA-constructs comprising intergenic ribosomal DNA and methods to produce proteins using these DNA-constructs
10/13/1999CN1231696A Homocysteine desulphurase from the protozoan trichomonas vaginalis
10/13/1999CN1231673A Polynucleotide and its use for modulating a defence response in plants
10/13/1999CN1045539C CDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophie cellular growth
10/12/1999US5965794 Viral amplification of recombinant messenger RNA in transgenic plants
10/12/1999US5965793 Strong early seed-specific gene regulatory region
10/12/1999US5965791 Vector for introducing a gene into a plant, and methods for producing transgenic plants and multitudinously introducing genes into a plant using the vector
10/12/1999US5965726 Method of eliminating inhibitory/ instability regions of mRNA
10/12/1999US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999US5965704 Class two cytokine receptor-11
10/12/1999US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes
10/12/1999US5965530 Therapeutic uses of keratinocyte growth factor
10/12/1999US5965438 Cryopreservation of plant cells
10/12/1999US5965437 Method of screening a compound for hematopoietic activity
10/12/1999US5965436 Method of isolating mesenchymal stem cells associated with isolated megakaryocytes by isolating megakaryocytes
10/12/1999US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999US5965425 Expression of pace in host cells and methods of use thereof
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965418 A protein which catalyzes the oxidation of halide ions in the presence of hydrogen peroxide; microbiocides
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965404 Adding nucleic acid/polycation complexes to animal cells in presence of ethylene glycol and/or glycerol; for simple and accurate transfection of cells for gene therapy and tumor vaccine production
10/12/1999US5965403 Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
10/12/1999US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965392 A nucleic acid molecule; treating obesity or anorexia
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965374 Glucan-specific assay
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/12/1999US5965367 Purified bradykinin B1 receptor
10/12/1999US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/12/1999US5965360 Diagnosis of metastatic cancer by the mts-1 gene
10/12/1999US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene
10/12/1999US5965353 An epitope; for a diagnostic kit
10/12/1999US5965305 Method for surface modification to create regions resistant to adsorption of biomolecules
10/12/1999US5965139 Chicken infectious anemia virus vaccine
10/12/1999US5965138 Recombinant chimeric virus and vaccine comprising a long viral genomic region from the herpes virus of turkeys and a short viral genomic region from marek's disease virus; immunizing birds
10/12/1999US5965134 Immunogenic composition against Classical Swine Fever Virus (CSFV)
10/12/1999US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer
10/12/1999US5965125 Hybrid matrix implants and explants
10/12/1999US5964807 Compositions and methods for intervertebral disc reformation
10/12/1999CA2096851C Tissue plasminogen activator substitution variant
10/12/1999CA1340781C Tumor specific monoclonal antibodies
10/07/1999WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999WO1999050432A1 Inducible alphaviral gene expression system